Representative Image | The English Post

Covid vaccine Corbevax gets Drug Controller’s Emergency Use Authorisation

New Delhi | India’s first indigenously-developed receptor binding domain (RBD) protein sub-unit Covid-19 vaccine, Corbevax, developed by Biological E Ltd, has received the Drug Controller General of India’s approval for Emergency Use Authorization (EUA). The Department of Biotechnology and its public sector undertaking, the Biotechnology Industry Research Assistance Council (BIRAC), had supported Biological E’s Covid-19 vaccine […]